Clinical Characteristics and Prognosis of Neuroendocrine Carcinoma in the Head and Neck: A Single-Institutional Retrospective Analysis
Current Oncology · 29.06.2026 · 33 (7) · 390
DOI: 10.3390/curroncol33070390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 29.06.2026. Verfasst von Chengyan Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, C…. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Head and neck neuroendocrine carcinoma (HN-NEC) is exceedingly rare. Standardized treatment strategies for this malignancy remain unestablished. This study aimed to explore promising treatment modalities, and to identify prognostic factors in HN-NEC. Materials and Methods: Thirty-nine patients diagnosed with HN-NEC at West China Hospital of Sichuan University between 2006 and 2025 were enrolled. The 5-year survival rates were estimated by Kaplan–Meier analysis. The log-rank test and Firth’s penalized Cox multivariable analysis regression model were used to identify prognostic factors.
Results
The 5-year locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS), and overall survival (OS) rates for patients who did and did not receive radiotherapy were 63.2% vs. 29.6% (p = 0.031), 75.5% vs. 48.0% (p = 0.065), and 81.4% vs. 46.9% (p = 0.039), respectively. Laryngeal NEC was associated with poorer 5-year DMFS (41.2% vs. 87.5%, p = 0.023) and 5-year OS (38.1% vs. 92.9%, p = 0.027) compared with non-laryngeal HN-NEC. Radiotherapy (HR = 0.152, 95% CI: 0.025–0.757, p = 0.022) was a potentially protective factor influencing LRRFS.
Conclusions
Radiotherapy may be associated with improved LRRFS in patients with HN-NEC. HN-NEC originating in the larynx appeared to be associated with a poorer prognosis compared with other primary sites of the head and neck.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Head & Neck Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China.
- Department of Oncology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China.
Zitieren
APA
Yang, C., Gao, K., He, S., Liu, M., & Ai, P. (2026). Clinical Characteristics and Prognosis of Neuroendocrine Carcinoma in the Head and Neck: A Single-Institutional Retrospective Analysis. Current Oncology, 33(7), 390. https://doi.org/10.3390/curroncol33070390
Vancouver
Yang C, Gao K, He S, Liu M, Ai P. Clinical Characteristics and Prognosis of Neuroendocrine Carcinoma in the Head and Neck: A Single-Institutional Retrospective Analysis. Current Oncology. 2026;33(7):390. doi:10.3390/curroncol33070390
BibTeX
@article{Yang2026,
author = {Yang, Chengyan and Gao, Kun and He, Shuangshuang and Liu, Mengyuan and Ai, Ping},
title = {Clinical Characteristics and Prognosis of Neuroendocrine Carcinoma in the Head and Neck: A Single-Institutional Retrospective Analysis},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {7},
pages = {390},
doi = {10.3390/curroncol33070390}
}
EUVIMED